BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2023 3:28:49 PM | Browse: 425 | Download: 1565
 |
Received |
|
2023-08-14 06:03 |
|
Peer-Review Started |
|
2023-08-14 06:06 |
|
First Decision by Editorial Office Director |
|
2023-09-19 06:11 |
|
Return for Revision |
|
2023-09-19 06:11 |
|
Revised |
|
2023-10-04 11:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-10-13 01:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-10-23 06:44 |
|
Articles in Press |
|
2023-10-23 06:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-10-25 04:14 |
|
Publish the Manuscript Online |
|
2023-10-27 15:28 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Aitoshi Hoshimoto, Atsushi Tatsuguchi, Ryohei Hamakubo, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Shu Tanaka, Shunji Fujimori, Tsutomu Hatori, Akira Shimizu and Katsuhiko Iwakiri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Atsushi Tatsuguchi, MD, PhD, Associate Professor, Department of Gastroenterology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. tachan@nms.ac.jp |
| Key Words |
Small bowel adenocarcinoma; Programmed cell death-ligand 1; Programmed cell death-ligand 2; Tumor microenvironment; Tumor-infiltrating lymphocytes; Regulatory T-cells |
| Core Tip |
We investigated the clinicopathological significance of programmed cell death-ligand 1 (PD-L1) and programmed cell death-ligand 2 (PD-L2) expression in association with the infiltration of FoxP3+ and CD8+ T cells into the tumor microenvironment (TME) to identify PD-L/PD-1 immunotherapy candidates among patients with small bowel adenocarcinoma (SBA). We demonstrated that the status of the TME affects the clinical significance of PD-L1 and PD-L2. PD-L2 may be associated with poor prognosis of SBA patients with a high immune cell infiltration. |
| Publish Date |
2023-10-27 15:28 |
| Citation |
Hoshimoto A, Tatsuguchi A, Hamakubo R, Nishimoto T, Omori J, Akimoto N, Tanaka S, Fujimori S, Hatori T, Shimizu A, Iwakiri K. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World J Gastroenterol 2023; 29(40): 5566-5581 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i40/5566.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i40.5566 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
